Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on IPSOS. We currently have 0 research reports from 0 professional analysts.
|22Feb17 17:19||GNW||Ipsos: 2016 Annual results|
|26Oct16 16:54||GNW||Ipsos: third quarter of 2016 - Positive confirmation|
|26Jul16 17:14||GNW||Ipsos: First-half 2016|
|11Jul16 06:31||GNW||Press release from LT Participations|
|27Apr16 17:08||GNW||IPSOS: First quarter of 2016 - A good market, a good quarter|
|17Feb16 17:35||GNW||IPSOS: 2015 Annual Results|
|21Oct15 16:36||GNW||IPSOS: Third quarter of 2015 - Market trend remains stable|
Frequency of research reports
Research reports on
Small Cap Breakfast
28 Mar 17
Path Investments—Publication of prospectus from the Energy Investment Company. Raising £1.4m. Admission due on or around 30 March | Franchise Brands—Schedule 1 detailing £28m reverse takeover of Metro Rod. Admission expected 11 April | Alpha FX Group— Schedule 1 from the foreign exchange provider focused on managing exchange rate risk for UK corporates that trade internationally. Fundraise TBC. Admission expected 7 April. | K3 | Capital Group—Schedule 1 from the Group of business and company sales specialists across business transfer, business brokerage and corporate finance. Admission date and fundraise details TBC. | Integumen— Schedule 1 from the personal health company developing and commercialising technology and products for the human integumentary system. Raising £2.16m at 5p. Expected market cap £8.16m. Admission expected 5 April. Tufton | Oceanic Assets– Offer extended to 9 May to enable investors to complete further due diligence.
Share & share alike
29 Mar 17
In a key week in a number of respects, some of the optimism that buoyed up markets has dissipated. In the UK, inflation istrending higher and above wage growth, putting pressure on the consumer although retail sales show contrasting signs. Corporate action continues apace. Yesterday there were more than fifty company results – all appear to be at least as expected. We now face a prolonged period of pre-Brexit bargaining. In Share News & Views we have covered Cropper (James)*, ECSC*, Gamma Communications, Goodwin*, Helios*, Manx Telecom, Personal Group and Quarto Group.-
Numbers in line, strategic review of refinancing options launched
29 Mar 17
Adjusted profits, cash flow and growth trends all look closely in line with the update provided in early February. In addition the IAS19 pension deficit has stepped up from £23m to £68m, and the board has confirmed it has commenced a strategic review of options for refinancing the £220m bond due June 2019. Q1 trading has shown a continuation of the improved trend noted in Q4 of 2016, and we make no changes to our profit forecasts or Target Price at this point. Clearly though, the actual out-turn may now depend on the outcome of the strategic review of refinancing options.
Executing the Growth Acceleration Plan
29 Mar 17
Ebiquity’s FY16 results reflect a continuation of trends seen at H116 and the early stages of the Growth Acceleration Plan. With additional services due to launch in FY17, we retain our forecasts for an acceleration of revenue growth in FY17 and introduce FY18 estimates. The transition to a more sustainable margin translates to a lower EPS figure overall but improves the quality of the earnings base and the sustainability of revenue growth. The c 12x P/E rating is unchallenging versus peers.
Small Cap Breakfast
23 Mar 17
K3 Capital Group—Schedule 1 from the Group of business and company sales specialists across business transfer, business brokerage and corporate finance. Admission date and fundraise details TBC. Integumen— Schedule 1 from the personal health company developing and commercialising technology and products for the human integumentary system. Raising £2.16m at 5p. Expected market cap £8.16m. Admission expected 5 April. Sentinel—Investment company expecting NEX admission/introduction on 24 March. £636k raised pre-IPO. BioPharma Credit—Expected Gross Initial Acquisition Proceeds now c.$338m. Gross Cash Proceeds capped at $423m with placing and open offer. Results expected 23 March with admission now due 30 march.